V1	V2	V3	V4	V5	V6	V7	V8	V9	V10	V11	V12	V13	V14	V15	V16
admin.batchnumber	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0	212.3.0
admin.bcr	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital	nationwide children's hospital
admin.dayofdccupload	18	18	18	18	18	18	18	18	18	18	18	18	18	18	18
admin.diseasecode	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc	dlbc
admin.monthofdccupload	7	7	7	7	7	7	7	7	7	7	7	7	7	7	7
admin.patientwithdrawal.withdrawn	false	false	false	false	false	false	false	false	false	false	false	false	false	false	false
admin.yearofdccupload	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013	2013
patient.ageatinitialpathologicdiagnosis	28	57	70	38	42	60	70	43	69	52	58	57	67	67	56
patient.bcrpatientbarcode	tcga-ff-8041	tcga-ff-8042	tcga-ff-8043	tcga-ff-8047	tcga-ff-8061	tcga-ff-8062	tcga-fm-8000	tcga-g8-6324	tcga-g8-6325	tcga-g8-6326	tcga-g8-6906	tcga-g8-6907	tcga-g8-6909	tcga-g8-6914	tcga-gr-7351
patient.bcrpatientuuid	1f971af1-6772-4fe6-8d35-bbe527a037fe	f0a326d2-1f3e-4a5d-bca8-32aaccc52338	a8e2df1e-4042-42af-9231-3a00e83489f0	f978cb0f-d319-4c01-b4c5-23ae1403a106	c8cde9ea-89e9-4ee8-8a46-417a48f6d3ab	0e9fcccc-0630-408d-a121-2c6413824cb7	e56e4d9c-052e-4ec6-a81b-dbd53e9c8ffe	6a21c948-cd85-4150-8c01-83017d7dc1ed	ea54dbad-1b23-41cc-9378-d4002a8fca51	f8cf647b-1447-4ac3-8c43-bef07765cabf	3f5a897d-1eaa-4d4c-8324-27ac07c90927	31bbad4e-3789-42ec-9faa-1cb86970f723	a468e725-ad4b-411d-ac5c-2eacc68ec580	3622cf29-600f-4410-84d4-a9afeb41c475	7a589441-11ef-4158-87e7-3951d86bc2aa
patient.blymphocytegenotypingmethod	NA	NA	NA	NA	NA	NA	NA	igh pcr	igh pcr	igh pcr	igh southern blot	igh southern blot	NA	NA	NA
patient.bonemarrowbiopsydone	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	yes	NA	NA	yes
patient.bonemarrowinvolvement	no	no	no	no	no	no	no	yes	no	yes	no	no	no	no	no
patient.clinicalcqcf.consentordeathstatus	consented	consented	consented	consented	consented	consented	consented	consented	consented	consented	consented	consented	consented	consented	consented
patient.clinicalcqcf.country	singapore	singapore	singapore	singapore	singapore	singapore	united states	united states	united states	united states	united states	united states	united states	united states	united states
patient.clinicalcqcf.daystoconsent	27	9	83	19	139	21	34	-6	-9	-2	2527	19	0	9	16
patient.clinicalcqcf.diagnosissubtype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.frozenspecimenanatomicsite	NA	NA	NA	NA	NA	NA	colon	NA	NA	NA	NA	NA	lymph node(s) mediastinal	NA	NA
patient.clinicalcqcf.histologicaltype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.historyofneoadjuvanttreatment	no	no	no	no	no	no	no	no	no	no	yes, pharmaceutical treatment prior to resection	no	no	no	no
patient.clinicalcqcf.historyofpriormalignancy	no	no	no	no	no	no	no	no	no	no	no	no	no	no	no
patient.clinicalcqcf.normaltissueanatomicsite	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.normaltissueproximity	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.otheranatomicsite	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	spleen	NA	NA	NA	NA
patient.clinicalcqcf.otheranatomicsitenormaltissue	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.priordx	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.clinicalcqcf.tumortype	primary	primary	primary	primary	primary	primary	primary	primary	primary	primary	primary	primary	primary	primary	primary
patient.dayofformcompletion	14	14	14	5	17	17	16	20	18	16	16	17	5	4	3
patient.daystobirth	-10466	-21004	-25612	-13996	-15358	-21958	-25720	-15750	-25256	-19238	-21271	-21021	-24661	-24568	-20812
patient.daystodeath	NA	NA	NA	NA	NA	NA	NA	1251	NA	NA	6425	595	NA	NA	NA
patient.daystoinitialpathologicdiagnosis	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
patient.daystolastfollowup	626	608	580	126	433	259	139	NA	1266	1161	NA	NA	3226	5616	3872
patient.drugs	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.easterncanceroncologygroup	0	0	1	2	0	0	NA	1	1	0	NA	NA	0	NA	1
patient.ebvantibodystatus	NA	NA	NA	NA	NA	NA	NA	NA	NA	negative	NA	NA	NA	NA	NA
patient.ebvdiagnosticmethodology	NA	NA	NA	NA	NA	NA	NA	NA	NA	eber in situ hybridization	NA	NA	NA	NA	NA
patient.ethnicity	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino	not hispanic or latino
patient.extranodaldiseaseinvolvementsites.extranodaldiseaseinvolvementsite	NA	NA	colon	NA	small intestine	thyroid	colon	ascites/peritoneum	NA	ascites/peritoneum	other extranodal site	NA	NA	NA	thyroid
patient.extranodaldiseaseinvolvementsites.extranodaldiseaseinvolvementsite-2	NA	NA	NA	NA	NA	NA	small intestine	NA	NA	other extranodal site	NA	NA	NA	NA	NA
patient.extranodaldiseaseinvolvementsites.extranodaldiseaseinvolvementsiteother	NA	NA	NA	NA	NA	NA	NA	NA	NA	omentum	spleen	NA	NA	NA	NA
patient.extranodaldiseaseinvolvementsites.numberofinvolvedextranodalsites	NA	NA	1	NA	1	1	2	1	0	2	1	0	0	NA	1
patient.followups	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.followups.followup.bcrfollowupbarcode	NA	NA	NA	tcga-ff-8047-f30870	NA	NA	NA	tcga-g8-6324-f37605	tcga-g8-6325-f40599	tcga-g8-6326-f40595	tcga-g8-6906-f32214	NA	tcga-g8-6909-f43062	tcga-g8-6914-f43065	NA
patient.followups.followup.bcrfollowupuuid	NA	NA	NA	965498ce-9854-437b-9290-d7ffb7c1398d	NA	NA	NA	a76cbef3-88e3-4092-aade-3227b48a5773	335060dd-20a3-4962-8ebe-7234a783b15a	9be12f53-fddc-4e4c-9374-7e92c741277a	6cecf8ea-7656-46d8-b423-84d7ca432b6d	NA	6bf9f37e-70eb-4747-9d70-b52672e24b62	c9bc9826-4e1e-4fe7-bf59-3c811503bfa3	NA
patient.followups.followup.dayofformcompletion	NA	NA	NA	5	NA	NA	NA	5	25	25	17	NA	9	10	NA
patient.followups.followup.daystodeath	NA	NA	NA	NA	NA	NA	NA	1251	NA	NA	6425	NA	3552	NA	NA
patient.followups.followup.daystolastfollowup	NA	NA	NA	126	NA	NA	NA	NA	1581	1441	NA	NA	NA	5980	NA
patient.followups.followup.followupcasereportformsubmissionreason	NA	NA	NA	additional new tumor event	NA	NA	NA	scheduled follow-up submission	scheduled follow-up submission	scheduled follow-up submission	scheduled follow-up submission	NA	scheduled follow-up submission	scheduled follow-up submission	NA
patient.followups.followup.lostfollowup	NA	NA	NA	NA	NA	NA	NA	no	no	no	NA	NA	no	no	NA
patient.followups.followup.monthofformcompletion	NA	NA	NA	1	NA	NA	NA	12	2	2	5	NA	5	5	NA
patient.followups.followup.newtumorevents.newtumorevent.daystonewtumoreventafterinitialtreatment	NA	NA	NA	24	NA	NA	NA	338	NA	NA	6383	NA	NA	3669	NA
patient.followups.followup.newtumorevents.newtumorevent.firstprogressionhistologytype	NA	NA	NA	diffuse large b-cell lymphoma	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.followups.followup.newtumorevents.newtumorevent.firstprogressionhistologytypeother	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.followups.followup.newtumorevents.newtumorevent.firstrecurrencebiopsyconfirmed	NA	NA	NA	yes	NA	NA	NA	no	NA	NA	NA	NA	NA	NA	NA
patient.followups.followup.newtumorevents.newtumorevent.followuptreatmentsuccess	NA	NA	NA	progressive disease	NA	NA	NA	progressive disease	stable disease	complete remission/response	NA	NA	complete remission/response	complete remission/response	NA
patient.followups.followup.newtumorevents.newtumorevent.newneoplasmeventoccurrenceanatomicsite	NA	NA	NA	leptomeninges	NA	NA	NA	supraclavicular lymph nodes	NA	NA	NA	NA	NA	NA	NA
patient.followups.followup.newtumorevents.newtumorevent.newneoplasmoccurrenceanatomicsitetext	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.followups.followup.newtumorevents.newtumorevent.petscanresults	NA	NA	NA	positive	NA	NA	NA	negative	not done	indeterminate	not done	NA	not done	not done	NA
patient.followups.followup.newtumorevents.newtumoreventafterinitialtreatment	NA	NA	NA	yes	NA	NA	NA	yes	no	no	yes	NA	no	yes	NA
patient.followups.followup.personneoplasmcancerstatus	NA	NA	NA	with tumor	NA	NA	NA	with tumor	tumor free	tumor free	tumor free	NA	tumor free	tumor free	NA
patient.followups.followup.primarytherapyoutcomesuccess	NA	NA	NA	progressive disease	NA	NA	NA	complete remission/response	stable disease	progressive disease	complete remission/response	NA	complete remission/response	complete remission/response	NA
patient.followups.followup.radiationtherapy	NA	NA	NA	no	NA	NA	NA	no	no	no	no	NA	no	no	NA
patient.followups.followup.targetedmoleculartherapy	NA	NA	NA	yes	NA	NA	NA	yes	yes	yes	yes	NA	yes	yes	NA
patient.followups.followup.vitalstatus	NA	NA	NA	living	NA	NA	NA	deceased	living	living	deceased	NA	deceased	living	NA
patient.followups.followup.yearofformcompletion	NA	NA	NA	2012	NA	NA	NA	2012	2013	2013	2012	NA	2013	2013	NA
patient.gender	female	female	female	female	male	female	female	female	male	male	male	female	male	male	female
patient.height	173	171	146	155	171	157	155.0	165.5	171	185	164.3	154.2	178	172	166.5
patient.histologicaltype	primary mediastinal (thymic) dlbcl	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)	diffuse large b-cell lymphoma (dlbcl) nos (any anatomic site nodal or extranodal)
patient.histologyofbonemarrowsample	NA	NA	NA	NA	NA	NA	discordant histology	discordant histology	NA	concordant histology	NA	NA	NA	NA	NA
patient.historyofneoadjuvanttreatment	no	no	no	no	no	no	no	no	no	no	yes	no	no	no	no
patient.hivpositivestatus	negative	negative	negative	negative	negative	negative	negative	negative	negative	negative	negative	negative	negative	negative	NA
patient.icd10	NA	NA	NA	NA	NA	NA	c83.39	NA	NA	NA	c83.33	c83.31	NA	c83.31	c83.39
patient.icdo3histology	9680/3	9680/3	9680/3	9680/3	9680/3	9680/3	9680/3	9680/3	9680/3	9680/3	9680/3	9680/3	NA	9680/3	9680/3
patient.icdo3site	NA	NA	NA	NA	NA	NA	c18.9	c77.2	c77.2	c77.2	c77.2	c77.0	NA	c77.0	c73.9
patient.ighgenotyperesults	NA	NA	NA	NA	NA	NA	not tested	clonal	clonal	clonal	non-clonal	non-clonal	NA	NA	NA
patient.igkgenotyperesults	NA	NA	NA	NA	NA	NA	not tested	NA	not tested	not tested	not tested	not tested	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-10.immunophenotypicanalysismethodology	NA	NA	NA	NA	NA	NA	NA	immunohistochemistry	NA	immunohistochemistry	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-10.immunophenotypicanalysistest	NA	NA	NA	NA	NA	NA	NA	pax5	NA	cd15	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-10.resultofimmunophenotypicanalysis	NA	NA	NA	NA	NA	NA	NA	positive	NA	negative	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-11.immunophenotypicanalysismethodology	NA	NA	NA	NA	NA	NA	NA	immunohistochemistry	NA	immunohistochemistry	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-11.immunophenotypicanalysistest	NA	NA	NA	NA	NA	NA	NA	cd5	NA	alk	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-11.resultofimmunophenotypicanalysis	NA	NA	NA	NA	NA	NA	NA	negative	NA	negative	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-12.immunophenotypicanalysismethodology	NA	NA	NA	NA	NA	NA	NA	flow cytometry	NA	NA	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-12.immunophenotypicanalysistest	NA	NA	NA	NA	NA	NA	NA	cd5	NA	NA	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-12.resultofimmunophenotypicanalysis	NA	NA	NA	NA	NA	NA	NA	negative	NA	NA	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-2.immunophenotypicanalysismethodology	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	flow cytometry	immunohistochemistry	immunohistochemistry	flow cytometry	immunohistochemistry	immunohistochemistry	flow cytometry	immunohistochemistry
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-2.immunophenotypicanalysistest	bcl2	bcl2	bcl2	bcl2	bcl2	bcl2	cd 10> 30%	cd 10> 30%	bcl2	cd20	cd 10> 30%	bcl2	bcl2	cd20	cd20
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-2.resultofimmunophenotypicanalysis	positive	positive	positive	positive	positive	negative	negative	negative	positive	positive	negative	positive	negative	positive	positive
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-3.immunophenotypicanalysismethodology	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	flow cytometry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	flow cytometry	immunohistochemistry
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-3.immunophenotypicanalysistest	cd20	cd20	cd20	cd20	cd20	cd20	cd20	bcl2	cd20	bcl6 > 30%	bcl2	cd20	cd20	cd22	bcl6 > 30%
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-3.resultofimmunophenotypicanalysis	positive	positive	positive	positive	positive	positive	positive	positive	positive	positive	positive	positive	positive	positive	positive
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-4.immunophenotypicanalysismethodology	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	NA	immunohistochemistry	immunohistochemistry	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-4.immunophenotypicanalysistest	mum1 > 30%	mum1 > 30%	mum1 > 30%	mum1 > 30%	mum1 > 30%	mum1 > 30%	mum1 > 30%	cd20	mum1 > 30%	mum1 > 30%	NA	cd23	bcl6 > 30%	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-4.resultofimmunophenotypicanalysis	positive	positive	positive	positive	positive	negative	negative	positive	positive	negative	NA	negative	negative	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-5.immunophenotypicanalysismethodology	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	flow cytometry	immunohistochemistry	immunohistochemistry	NA	immunohistochemistry	immunohistochemistry	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-5.immunophenotypicanalysistest	bcl6 > 30%	bcl6 > 30%	bcl6 > 30%	bcl6 > 30%	bcl6 > 30%	cyclin d1	bcl6 > 30%	cd20	bcl6 > 30%	cd23	NA	cd5	cd23	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-5.resultofimmunophenotypicanalysis	positive	positive	positive	positive	positive	negative	positive	positive	positive	negative	NA	negative	negative	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-6.immunophenotypicanalysismethodology	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	NA	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	NA	NA	immunohistochemistry	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-6.immunophenotypicanalysistest	cd23	cd23	cd5	cyclin d1	pax5	NA	cd23	mum1 > 30%	cd30	cd79a	NA	NA	cd5	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-6.resultofimmunophenotypicanalysis	negative	negative	negative	negative	positive	NA	positive	positive	negative	positive	NA	NA	negative	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-7.immunophenotypicanalysismethodology	immunohistochemistry	immunohistochemistry	immunohistochemistry	NA	NA	NA	immunohistochemistry	immunohistochemistry	NA	immunohistochemistry	NA	NA	immunohistochemistry	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-7.immunophenotypicanalysistest	cd30	cd79a	cyclin d1	NA	NA	NA	pax5	bcl6 > 30%	NA	pax5	NA	NA	cd30	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-7.resultofimmunophenotypicanalysis	positive	positive	negative	NA	NA	NA	positive	positive	NA	positive	NA	NA	negative	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-8.immunophenotypicanalysismethodology	immunohistochemistry	immunohistochemistry	NA	NA	NA	NA	immunohistochemistry	immunohistochemistry	NA	immunohistochemistry	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-8.immunophenotypicanalysistest	cyclin d1	cd5	NA	NA	NA	NA	cd5	cd23	NA	cd5	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-8.resultofimmunophenotypicanalysis	negative	negative	NA	NA	NA	NA	positive	positive	NA	negative	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-9.immunophenotypicanalysismethodology	NA	immunohistochemistry	NA	NA	NA	NA	immunohistochemistry	flow cytometry	NA	immunohistochemistry	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-9.immunophenotypicanalysistest	NA	cyclin d1	NA	NA	NA	NA	cyclin d1	cd23	NA	cd30	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult-9.resultofimmunophenotypicanalysis	NA	negative	NA	NA	NA	NA	negative	positive	NA	negative	NA	NA	NA	NA	NA
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult.immunophenotypicanalysismethodology	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	immunohistochemistry	flow cytometry	flow cytometry	immunohistochemistry	immunohistochemistry	flow cytometry	immunohistochemistry	immunohistochemistry	flow cytometry	immunohistochemistry
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult.immunophenotypicanalysistest	cd 10> 30%	cd 10> 30%	cd 10> 30%	cd 10> 30%	cd 10> 30%	cd 10> 30%	cd19	cd19	cd 10> 30%	cd 10> 30%	cd19	cd 10> 30%	cd 10> 30%	cd19	cd 10> 30%
patient.immunophenotypicanalysisresults.immunophenotypicanalysisresult.resultofimmunophenotypicanalysis	negative	negative	negative	negative	positive	positive	positive	positive	negative	negative	positive	positive	negative	positive	positive
patient.informedconsentverified	yes	yes	yes	yes	yes	yes	yes	yes	yes	yes	yes	yes	yes	yes	yes
patient.ldhlabvalue	499	461	536	667	414	682	321	498	NA	964	325	628	NA	NA	498
patient.ldhupperlimit	380	380	380	380	380	380	260	618	618	618	185	618	NA	NA	618
patient.maximumtumorbulkanatomiclocation	mediastinal	supraclavicular ln	colon	cervical	small intestine	thyroid	colon	NA	NA	NA	NA	NA	NA	NA	thyroid
patient.maximumtumordimension	12	1.5	0.4	2.0	15	2.0	12	NA	NA	NA	NA	NA	NA	NA	5.5
patient.mib1positivepercentagerange	76 - 100%	76 - 100%	76 - 100%	76 - 100%	76 - 100%	76 - 100%	26 - 50%	51 - 75%	51 - 75%	NA	NA	NA	NA	NA	NA
patient.monthofformcompletion	12	12	12	1	1	1	5	4	4	4	5	5	4	4	7
patient.newtumorevents.newtumorevent.daystonewtumoreventafterinitialtreatment	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	279	NA	NA	NA
patient.newtumorevents.newtumorevent.firstprogressionhistologytype	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent.firstprogressionhistologytypeother	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent.firstrecurrencebiopsyconfirmed	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	no	NA	NA	NA
patient.newtumorevents.newtumorevent.followuptreatmentsuccess	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent.newneoplasmeventoccurrenceanatomicsite	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ovary	NA	NA	NA
patient.newtumorevents.newtumorevent.newneoplasmoccurrenceanatomicsitetext	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.newtumorevents.newtumorevent.petscanresults	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	not done	NA	NA	negative
patient.newtumorevents.newtumoreventafterinitialtreatment	NA	NA	NA	NA	NA	NA	no	NA	NA	NA	NA	yes	NA	NA	no
patient.nodalanatomicsites.nodalanatomicsite	mediastinal	cervical	mesenteric	cervical	mesenteric	NA	NA	mesenteric	retroperitoneal	mesenteric	para-aortic	cervical	mediastinal	cervical	NA
patient.nodalanatomicsites.nodalanatomicsite-2	NA	supraclavicular	NA	inguinal	NA	NA	NA	NA	NA	NA	retroperitoneal	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-2.abnormalitytestedmethodology	fish	fish	fish	fish	fish	fish	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-2.abnormalitytestedresults	normal	normal	normal	translocation	translocation	normal	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-2.othergeneticabnormalitytested	pax5	igh	igh	igh	igh	igh	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-3.abnormalitytestedmethodology	NA	NA	NA	NA	NA	fish	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-3.abnormalitytestedresults	NA	NA	NA	NA	NA	normal	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-3.othergeneticabnormalitytested	NA	NA	NA	NA	NA	igk	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-4.abnormalitytestedmethodology	NA	NA	NA	NA	NA	fish	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-4.abnormalitytestedresults	NA	NA	NA	NA	NA	normal	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality-4.othergeneticabnormalitytested	NA	NA	NA	NA	NA	igl	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality.abnormalitytestedmethodology	fish	fish	fish	fish	fish	fish	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality.abnormalitytestedresults	normal	normal	normal	normal	normal	normal	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.othertestedgeneticabnormalities.othertestedgeneticabnormality.othergeneticabnormalitytested	igh	pax5	pax5	pax5	pax5	pax5	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.patientid	8041	8042	8043	8047	8061	8062	8000	6324	6325	6326	6906	6907	6909	6914	7351
patient.percentageoffollicularcomponent	< or = 10%	< or = 10%	< or = 10%	< or = 10%	< or = 10%	< or = 10%	< or = 10%	NA	NA	NA	NA	NA	NA	NA	< or = 10%
patient.percentebvpositivemalignantcells	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.personneoplasmcancerstatus	tumor free	tumor free	tumor free	with tumor	tumor free	tumor free	tumor free	with tumor	tumor free	tumor free	tumor free	with tumor	tumor free	tumor free	tumor free
patient.primarytherapyoutcomesuccess	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	stable disease	NA	NA	complete remission/response
patient.priordx	no	no	no	no	no	no	no	no	no	no	no	no	no	no	no
patient.priorimmunologicdiseasetypes.priorimmunologicdiseaseother	NA	NA	NA	NA	NA	NA	diverticulitis requiring colectomy 3/2008	NA	non-insulin dependent diabetes mellitus	NA	NA	NA	NA	NA	NA
patient.priorimmunologicdiseasetypes.priorimmunologicdiseasetype	NA	NA	NA	NA	NA	NA	other	NA	rheumatoid arthritis	NA	NA	NA	NA	NA	hashimoto's thyroiditis
patient.priorimmunologicdiseasetypes.priorimmunologicdiseasetype-2	NA	NA	NA	NA	NA	NA	NA	NA	other	NA	NA	NA	NA	NA	NA
patient.priorimmunosuppressivetherapytypes.priorimmunosuppressivetherapyother	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.priorimmunosuppressivetherapytypes.priorimmunosuppressivetherapytype	none	none	none	none	none	none	none	none	methotrexate	none	NA	none	none	none	none
patient.priorinfectiousdisease	NA	hepatitis b virus	hepatitis b virus	hepatitis b virus	NA	hepatitis b virus	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.priorinfectiousdiseaseother	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.race	asian	asian	asian	asian	asian	asian	white	black or african american	white	white	white	white	white	white	white
patient.radiations	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.anatomictreatmentsite	NA	NA	NA	NA	NA	NA	NA	distant site	NA	NA	NA	NA	NA	NA	primary tumor field
patient.radiations.radiation.bcrradiationbarcode	NA	NA	NA	NA	NA	NA	NA	tcga-g8-6324-r34298	NA	NA	tcga-g8-6906-r32225	tcga-g8-6907-r32160	NA	NA	tcga-gr-7351-r33603
patient.radiations.radiation.bcrradiationuuid	NA	NA	NA	NA	NA	NA	NA	be898cc8-3cc9-4079-a464-64c648a61dcf	NA	NA	f5e84cfc-5ca6-4407-9731-221662353ae8	39a73be1-2a0f-4e4a-afee-d69586f49c4c	NA	NA	909ac6cb-8e8a-4069-a8de-2fe047b9f959
patient.radiations.radiation.coursenumber	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	1	NA	NA	NA
patient.radiations.radiation.dayofformcompletion	NA	NA	NA	NA	NA	NA	NA	7	NA	NA	17	17	NA	NA	12
patient.radiations.radiation.daystoradiationtherapyend	NA	NA	NA	NA	NA	NA	NA	590	NA	NA	2648	385	NA	NA	141
patient.radiations.radiation.daystoradiationtherapystart	NA	NA	NA	NA	NA	NA	NA	562	NA	NA	2646	383	NA	NA	112
patient.radiations.radiation.measureofresponse	NA	NA	NA	NA	NA	NA	NA	stable disease	NA	NA	NA	NA	NA	NA	complete response
patient.radiations.radiation.monthofformcompletion	NA	NA	NA	NA	NA	NA	NA	8	NA	NA	5	5	NA	NA	7
patient.radiations.radiation.numfractions	NA	NA	NA	NA	NA	NA	NA	20	NA	NA	6	5	NA	NA	22
patient.radiations.radiation.radiationdosage	NA	NA	NA	NA	NA	NA	NA	40	NA	NA	1200	1000	NA	NA	39.6
patient.radiations.radiation.radiationtreatmentongoing	NA	NA	NA	NA	NA	NA	NA	no	NA	NA	no	no	NA	NA	no
patient.radiations.radiation.radiationtype	NA	NA	NA	NA	NA	NA	NA	external	NA	NA	external beam	external beam	NA	NA	external
patient.radiations.radiation.radiationtypenotes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.regimenindication	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	adjuvant	progression	NA	NA	NA
patient.radiations.radiation.regimenindicationnotes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.radiations.radiation.units	NA	NA	NA	NA	NA	NA	NA	gy	NA	NA	cgy	cgy	NA	NA	gy
patient.radiations.radiation.yearofformcompletion	NA	NA	NA	NA	NA	NA	NA	2012	NA	NA	2012	2012	NA	NA	2012
patient.radiationtherapy	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	no	NA	NA	yes
patient.stageevent.annarbor.bsymptoms	no	no	no	no	yes	no	no	no	yes	yes	yes	no	no	no	no
patient.stageevent.annarbor.extranodalinvolvement	no	no	yes	no	yes	yes	yes	yes	no	yes	yes	no	no	no	yes
patient.stageevent.clinicalstage	stage i	stage ii	stage ii	stage ii	stage ii	stage i	stage ii	stage iv	stage iv	stage iv	NA	stage iv	stage iii	stage iii	stage i
patient.stageevent.gleasongrading.gleasonscore	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.gleasongrading.primarypattern	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.gleasongrading.secondarypattern	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.gleasongrading.tertiarypattern	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.pathologicstage	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.psa.daystopsa	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.psa.psavalue	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.systemversion	7th	7th	7th	7th	7th	7th	7th	6th	6th	6th	NA	5th	5th	4th	NA
patient.stageevent.tnmcategories.clinicalcategories.clinicalm	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.clinicalcategories.clinicaln	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.clinicalcategories.clinicalt	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.pathologiccategories.pathologicm	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.pathologiccategories.pathologicn	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.stageevent.tnmcategories.pathologiccategories.pathologict	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.targetedmoleculartherapy	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	yes	NA	NA	yes
patient.testedgeneticabnormalities.testedgeneticabnormality-2.abnormalitytestedmethodology	fish	fish	fish	fish	fish	fish	NA	fish	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-2.abnormalitytestedresults	normal	translocation	normal	normal	normal	normal	NA	normal	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-2.geneticabnormalitytested	bcl2	bcl2	bcl2	bcl2	bcl2	bcl2	NA	bcl6	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-3.abnormalitytestedmethodology	fish	fish	fish	fish	fish	fish	NA	fish	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-3.abnormalitytestedresults	normal	normal	normal	translocation	normal	normal	NA	normal	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-3.geneticabnormalitytested	bcl6	bcl6	bcl6	bcl6	bcl6	bcl6	NA	ccnd1	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-4.abnormalitytestedmethodology	fish	fish	fish	fish	fish	fish	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-4.abnormalitytestedresults	normal	normal	normal	normal	normal	normal	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-4.geneticabnormalitytested	ccnd1	ccnd1	ccnd1	ccnd1	ccnd1	ccnd1	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-5.abnormalitytestedmethodology	fish	fish	fish	fish	fish	fish	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-5.abnormalitytestedresults	normal	normal	normal	normal	normal	normal	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality-5.geneticabnormalitytested	malt1	malt1	malt1	malt1	malt1	malt1	NA	NA	NA	NA	NA	NA	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality.abnormalitytestedmethodology	fish	fish	fish	fish	fish	fish	NA	fish	NA	NA	NA	pcr	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality.abnormalitytestedresults	normal	normal	normal	translocation	normal	normal	NA	normal	NA	NA	NA	normal	NA	NA	NA
patient.testedgeneticabnormalities.testedgeneticabnormality.geneticabnormalitytested	c-myc	c-myc	c-myc	c-myc	c-myc	c-myc	NA	bcl2	NA	NA	NA	bcl2	NA	NA	NA
patient.tissueprospectivecollectionindicator	no	no	no	yes	yes	yes	yes	no	no	no	no	no	no	no	no
patient.tissueretrospectivecollectionindicator	yes	yes	yes	no	no	no	no	yes	yes	yes	yes	yes	yes	yes	yes
patient.tissuesourcesite	ff	ff	ff	ff	ff	ff	fm	g8	g8	g8	g8	g8	g8	g8	gr
patient.vitalstatus	living	living	living	living	living	living	living	deceased	living	living	deceased	deceased	living	living	living
patient.weight	58.9	89.9	41.5	52.5	48.1	60.1	69.5	60	105.7	127.7	59.2	91.8	90.5	72.5	77.5
patient.yearofformcompletion	2011	2011	2011	2012	2012	2012	2012	2012	2012	2012	2012	2012	2012	2012	2012
patient.yearofinitialpathologicdiagnosis	2010	2010	2010	2011	2010	2011	2011	2006	2008	2009	1987	2000	2002	1996	2001
